Novogen Ltd (NVGN.OQ)

NVGN.OQ on NASDAQ Stock Exchange Capital Market

1.87USD
26 Nov 2014
Price Change (% chg)

$0.08 (+4.47%)
Prev Close
$1.79
Open
$1.95
Day's High
$2.09
Day's Low
$1.87
Volume
2,100
Avg. Vol
4,354
52-wk High
$5.69
52-wk Low
$1.51

NVGN.OQ

Chart for NVGN.OQ

About

Novogen Limited is engaged in pharmaceutical research and development, and marketing of consumer healthcare products. The Company has three segments: Drug Development, Oncology Drug Program, Consumer Business and Wound Healing. Drug Development includes the discovery of new compounds and the early stage screening for bioactivity... (more)
No analyst recommendations are available for NVGN.OQ.

Overall

Beta: 0.94
Market Cap (Mil.): $14.51
Shares Outstanding (Mil.): 7.46
Dividend: --
Yield (%): --

Financials

  NVGN.OQ Industry Sector
P/E (TTM): -- 219.87 38.74
EPS (TTM): -1.01 -- --
ROI: -272.66 -2.35 17.27
ROE: -269.02 -3.55 18.18
Search Stocks

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: irasia.com
$23.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks